Jim Simons Forward Pharma A/S Transaction History

Renaissance Technologies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$4.24 - $6.03 $42,400 - $60,300	-10,000 Reduced 40.82%	14,500 $65,000
Q1 2022 May 13, 2022	SELL	$5.06 - $6.15 $86,526 - $105,165	-17,100 Reduced 41.11%	24,500 $142,000
Q4 2021 Feb 11, 2022	SELL	$5.43 - $7.01 $250,866 - $323,862	-46,200 Reduced 52.62%	41,600 $248,000
Q3 2021 Nov 12, 2021	BUY	$5.97 - $17.66 $524,166 - $1.55 Million	87,800 New	87,800 $597,000
Q2 2021 Aug 13, 2021	SELL	$6.77 - $8.6 $431,249 - $547,820	-63,700 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$6.51 - $9.0 $84,271 - $116,505	12,945 Added 25.5%	63,700 $436,000
Q4 2020 Feb 10, 2021	BUY	$6.22 - $7.4 $110,691 - $131,690	17,796 Added 53.99%	50,755 $357,000
Q3 2020 Nov 13, 2020	SELL	$5.99 - $6.78 $6,816 - $7,715	-1,138 Reduced 3.34%	32,959 $204,000
Q2 2020 Aug 13, 2020	BUY	$5.16 - $7.77 $175,940 - $264,933	34,097 New	34,097 $210,000

Ticker FWP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,091,180
Market Cap $18.2M
Description
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.